Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Second pharmacokinetic study of ND0612

Trial Profile

Second pharmacokinetic study of ND0612

Phase of Trial: Phase I

Latest Information Update: 11 May 2017

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 May 2017 According to a NeuroDerm media release, this trial initiation anticipated in the second half of 2017.
    • 05 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top